Functional Genetics Inc.
This article was originally published in Start Up
Executive Summary
Functional Genetics has developed a method for simultaneously knocking out both alleles of a gene, even when that gene is not known. The technology enables the company to better associate gene with disease process and function up front in the drug discovery process.
You may also be interested in...
Intra-Cellular Therapies Inc.
Built on technology from the lab of Nobel laureate Paul Greengard, PhD, Intra-Cellular Therapies Inc. aims to develop small-molecule compounds that modify intracellular responses to endogenous neurotransmitters as therapeutics for Parkinson's disease, depression, schizophrenia and other CNS disorders.
Understanding How To Develop BTK Inhibitors In MS Is Evolving
Having a reversible BTK inhibitor in the multiple sclerosis armamentarium could be the best way to favorably impact the treatment landscape.
Science Matters: Setting The Stage For Using Wearables In Oncology Drug Development
Digital biomarkers using data collected with wearable devices are making their way into clinical trials, largely in cardiovascular, respiratory and rare disease settings around physical activity metrics.